In light of the COVID-19 pandemic and challenges faced by all health research stakeholders, changes have been made to the 2020 HRC Global Alliance for Chronic Diseases Cancer Call timeline. The registration and full application deadlines have been extended, as indicated in the ‘Important dates’ section of this page. Due to these changes, the HRC is expecting to advise applicants of funding outcomes in March/April 2021. All details about this funding opportunity are available in the 2020 HRC Global Alliance for Chronic Diseases Cancer Call Request for Proposals and 2020 HRC Global Alliance for Chronic Diseases Cancer Call Application Guidelines documents (available below), but please note that application closing dates now differ to those listed in the Request for Proposals and Application Guidelines.
The Health Research Council of New Zealand (HRC) is seeking to fund implementation research for the primary and/or secondary prevention of cancer within Māori and/or Pacific populations.
This initiative is part of the Global Alliance for Chronic Diseases’ (GACD) joint funding call to invest in innovative research on cancer prevention. Research funded through this call should aim to adapt and scale-up implementation of successful interventions, in equitable, accessible, and affordable ways, to improve the prevention and early diagnosis of cancer in real-world settings.
Total funding of $2,000,000 (exclusive of GST) is available. This is expected to fund one to four projects, for a maximum duration of 36 months each. The Ministry of Health and the Cancer Control Agency will provide in-kind support to successful recipients during contract delivery, which may include appropriate access to data and contributions or feedback from the Cancer Control Agency team.
It is anticipated that the contracted projects will begin as soon as practicable, with funding available for an immediate start following notification of outcomes in March/April 2021.
The proposed research must be within scope of this initiative as specified in this RFP and must realistically be able to be completed within the prescribed maximum timeframe of 36 months.
If you’re the first-named investigator (i.e. lead researcher) on an application, you must be based in New Zealand and employed with a New Zealand host organisation.
Collaborating researchers from outside New Zealand can, at the HRC’s discretion, be included as named investigators on an HRC contract. However, the HRC will not contribute to the overhead of the overseas investigator, and the total proportion of contract budget allocated to overseas investigators must not exceed 20 percent.
For more information about our contract requirements, please read the HRC Rules document under ‘Helpful links’.
If you’re applying for funding through this initiative, you’ll need to submit a registration via HRC Gateway. You’ll then need to complete a full application using the 2020 HRC-GACD Cancer Call Application Form. You will also need to complete the 2020 HRC-GACD Budget Form. Full applications are submitted via HRC Gateway and two hard copies sent to the HRC.
Got a question?
If you’ve read through the documents below and the ‘How to apply for HRC funding’ section under ‘Helpful links’ and still have a question about the 2020 HRC Global Alliance for Chronic Diseases Cancer Call please email Mr Stacey Pene , Senior Manager, Māori Health Research Investment, or phone Stacey on 09 303 5225.
Request for proposals
2020 HRC Global Alliance for Chronic Diseases Cancer Call Request for Proposals
28 Feb, 2020 2:23pm - 274KB
2020 HRC Global Alliance for Chronic Diseases Cancer Call Application Guidelines
28 Feb, 2020 2:22pm - 438KB